PMS1 Postmeiotic Segregation Increased 1 (S. Cerevisiae) (PMS1) (Middle Region) Peptide
PMS1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5511444
Aperçu rapide pour PMS1 Postmeiotic Segregation Increased 1 (S. Cerevisiae) (PMS1) (Middle Region) Peptide (ABIN5511444)
Antigène
PMS1
(PMS1 Postmeiotic Segregation Increased 1 (S. Cerevisiae) (PMS1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- PFQNDMHNDE SGKNTDDCLN HQISIGDFGY GHCSSEISNI DKNTKNAFQD
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- PMS1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PMS1 (PMS1 Postmeiotic Segregation Increased 1 (S. Cerevisiae) (PMS1))
-
Sujet
-
This gene encodes a protein belonging to the DNA mismatch repair mutL/hexB family. This protein is thought to be involved in the repair of DNA mismatches, and it can form heterodimers with MLH1, a known DNA mismatch repair protein. Mutations in this gene cause hereditary nonpolyposis colorectal cancer type 3 (HNPCC3) either alone or in combination with mutations in other genes involved in the HNPCC phenotype, which is also known as Lynch syndrome.
Alias Symbols: MLH2, PMSL1, hPMS1, HNPCC3
Protein Size: 932 -
ID gène
- 5378
-
NCBI Accession
- NM_000534, NP_000525
-
UniProt
- P54277
Antigène
-
Vous êtes ici:
